Related Pages Search for Clinical Trials 1 NCI's PDQ® Cancer Clinical Trials Registry. Breast Cancer Home Page 2 NCI's gateway for information about breast cancer. Breast Cancer - Featured Clinical Trials The following list shows Featured Clinical Trials for a specific type of cancer. You may also want to view: Multiple Cancer Types - Featured Clinical Trials 3 Supportive Care - Featured Clinical Trials 4 1.  Adjuvant Bisphosphonates for Breast Cancer 5 (Posted: 07/25/2006, Updated: 02/09/2010) - Drugs called bisphosphonates may be able to prevent bone metastases in women with early breast cancer. With this trial, researchers are comparing a bisphosphonate called clodronate with two newer, more-potent bisphosphonates--zoledronate and ibandronate--in women with stage I-III breast cancer. 2.  Adjuvant Bevacizumab and Chemotherapy for High-risk Breast Cancer 6 (Posted: 01/26/2010) - In this trial, patients with lymph node-positive or high-risk, lymph node-negative breast cancer who have received radiation therapy or plan to do so following chemotherapy will be treated with adjuvant chemotherapy and randomly assigned to receive short-term treatment with bevacizumab, long-term treatment with bevacizumab, or an intravenous placebo. 3.  Targeting HER2 in the Treatment of Ductal Carcinoma in Situ 7 (Posted: 10/06/2009) - In this clinical trial, women with HER2-positive DCIS will be treated with lumpectomy followed by whole-breast radiation therapy; half of the women will also receive two doses of trastuzumab during their radiation treatment. 4.  Testing a New Drug in Advanced BRCA-related Cancer 8 (Posted: 09/08/2009) - In this clinical trial, women with advanced breast or ovarian cancer who carry a known BRCA gene mutation or who have a strong family history of these diseases (and are, therefore, likely to carry such a mutation) will be treated with a new drug called AZD2281 (olaparib) together with the chemotherapy drug carboplatin. 5.  Optimizing Postoperative Chemotherapy for Breast Cancer 9 (Posted: 06/16/2009) - In this trial, women with early-stage breast cancer deemed by their doctors to be at high risk for recurrence will receive adjuvant chemotherapy with either cyclophosphamide and doxorubicin or paclitaxel given four times over an 8-week period. 1 2 10 3 11 4 12   Next > 10

Table of Links

1	http://www.cancer.gov/clinicaltrials/search
2	http://www.cancer.gov/cancertopics/types/breast
3	http://www.cancer.gov/clinicaltrials/ft-more-than-one-type
4	http://www.cancer.gov/clinicaltrials/ft-supportive-care
5	http://www.cancer.gov/clinicaltrials/ft-SWOG-S0307
6	http://www.cancer.gov/clinicaltrials/ft-ECOG-E5103
7	http://www.cancer.gov/clinicaltrials/ft-NSABP-B-43
8	http://www.cancer.gov/clinicaltrials/ft-NCI-08-C-0092
9	http://www.cancer.gov/clinicaltrials/ft-CALGB-40101
10	http://www.cancer.gov/clinicaltrials/ft-breast-cancer?keyword=breast&page=2
11	http://www.cancer.gov/clinicaltrials/ft-breast-cancer?keyword=breast&page=3
12	http://www.cancer.gov/clinicaltrials/ft-breast-cancer?keyword=breast&page=4